Physician Assistant, Medical · Golden Valley, MN
NPI
1831595545
Since 2014
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8401 Golden Valley Rd Ste 340
Golden Valley, MN, 55427
Phone (952) 960-9399
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
212 services
Medicare patients, 2024
131
Average age 75
Drug cost, 2024
$1.0M
1,699 prescriptions
Company payments, 2025
$235
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kayla Halleron was code 99214 (office e&m - established), 114 times for 91 patients. In total Kayla Halleron billed 212 services in 10 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 114 | 91 | $53.68 | $6,119 |
| 99215 Office E&M - Established | Facility | 26 | 24 | $77.76 | $2,022 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 12 | $50.17 | $1,304 |
| 99213 Office E&M - Established | Facility | 16 | 16 | $39.60 | $634 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $82.74 | $993 |
By year: 2022 $22K for 422 services; 2023 $17K for 303 services; 2024 $12K for 212 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kayla Halleron prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 385 prescriptions and refills. In total Kayla Halleron wrote 1,699 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 385 | 484 | 76 | $309K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 106 | 120 | 31 | $16K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 105 | 107 | 45 | $3,851 |
| Montelukast Sodium Generic | 103 | 195 | 31 | $898 |
| Breo Ellipta Fluticasone/Vilanterol | 96 | 108 | 22 | $42K |
| Incruse Ellipta Umeclidinium Bromide | 88 | 100 | 16 | $30K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 71 | 77 | 12 | $36K |
| Prednisone Generic | 70 | 84 | 36 | $153 |
| Ventolin Hfa Albuterol Sulfate | 66 | 73 | 32 | $4,438 |
| Advair Hfa Fluticasone Propion/Salmeterol | 58 | 60 | Under 11 | $23K |
| Omeprazole Generic | 57 | 90 | 18 | $614 |
| Spiriva Respimat Tiotropium Bromide | 52 | 56 | 12 | $28K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 48 | 66 | 12 | $5,489 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 40 | 40 | Under 11 | $19K |
| Fluticasone Propionate Generic | 32 | 53 | 15 | $361 |
Brand drugs: 1,197 claims; generic drugs: 502 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kayla Halleron $235 ($235 in general payments such as food, travel and fees) from 5 companies. The largest payer was Terumo Medical Corporation with $107.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.